CVS Insider Trading
CVS HEALTH Corp | Retail-Drug Stores and Proprietary Stores
Comprehensive Trading Performance Summary
The investment history of corporate insiders at CVS HEALTH Corp provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Retail-Drug Stores and Proprietary Stores sector.
Transactions on Chart
Open Full Chart| Filing Date | Trade Date | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|
| 2026-01-28 01:20 | 2025-01-23 | Nelson Steven H | Officer - EVP and President, Aetna | BUY | $53.70 | 24 | $1,289 | 24 | +100.0% |
| 2025-10-15 02:08 | 2024-09-09 | CAPOZZI HEIDI B | Officer - EVP and Chief People Officer | BUY | $57.36 | 80 | $4,589 | 85 | +1,600.0% |
| 2025-08-29 23:29 | 2025-08-20 | Finucane Anne A. | Director | SELL | $71.02 | 7,500 | $532,650 | 22,156 | -25.3% |
| 2025-06-09 15:22 | 2025-06-05 | SANSONE GUY P | Director | BUY | $63.70 | 1,570 | $100,009 | 12,007 | +15.0% |
| 2025-05-06 23:15 | 2025-05-02 | ROBBINS LARRY | Director | SELL | $67.65 | 3,750,000 | $253,695,375 | 8,196,799 | -31.4% |
| 2025-03-08 00:56 | 2025-03-05 | Clark James David | Officer - SVP, Cont & Chief Acct Officer | OPT+S | $66.35 | 7,513 | $498,488 | 8,394 | 0.0% |
| 2025-02-19 20:35 | 2025-02-18 | Mahoney Michael F | Director | BUY | $66.70 | 30,000 | $2,001,000 | 39,356 | +320.6% |
| 2024-05-02 23:30 | 2024-05-02 | Mahoney Michael F | Director | BUY | $54.49 | 9,181 | $500,294 | 9,356 | +5,246.3% |
| 2024-05-02 23:31 | 2024-05-02 | LUDWIG EDWARD J | Director | BUY | $53.88 | 1,000 | $53,879 | 21,630 | +4.8% |
| 2024-02-17 02:46 | 2024-02-16 | Shah Prem S | Officer - EVP and Pres-Pharm, Consumer W | SELL | $76.95 | 29,473 | $2,267,947 | 39,765 | -42.6% |
| 2023-11-06 18:59 | 2023-11-03 | LUDWIG EDWARD J | Director | BUY | $70.47 | 2,000 | $140,930 | 20,630 | +10.7% |
| 2023-08-05 00:41 | 2023-08-03 | Clark James David | Officer - SVP, Cont & Chief Acct Officer | SELL | $74.92 | 25,759 | $1,930,004 | 4,698 | -84.6% |
| 2023-05-05 15:27 | 2023-05-03 | Lynch Karen S | Director, Officer - President and CEO | BUY | $69.75 | 14,000 | $976,567 | 431,392 | +3.4% |
| 2022-12-17 00:14 | 2022-12-15 | Moriarty Thomas M | Officer - EVP & General Counsel | OPT+S | $98.36 | 137,466 | $13,521,183 | 608,129 | 0.0% |
| 2022-08-05 23:48 | 2022-08-03 | Finke Daniel P | Officer - EVP/Pres, Health Care Benefits | OPT+S | $100.00 | 9,546 | $954,600 | 32,150 | 0.0% |
| 2022-08-05 23:50 | 2022-08-03 | Lotvin Alan | Officer - EVP&President-PharmacyServices | OPT+S | $98.94 | 143,440 | $14,192,370 | 109,183 | 0.0% |
| 2022-07-01 00:00 | 2022-06-28 | Moriarty Thomas M | Officer - EVP & General Counsel | OPT+S | $95.00 | 138,654 | $13,172,130 | 626,273 | 0.0% |
| 2022-04-12 23:51 | 2022-04-08 | Shah Prem S | Officer - EVP and Co-President of Retail | OPT+S | $105.00 | 16,954 | $1,780,170 | 43,453 | 0.0% |
| 2022-04-07 00:02 | 2022-04-04 | Finke Daniel P | Officer - EVP/Pres, Health Care Benefits | OPT+S | $100.12 | 61,300 | $6,137,197 | 32,150 | 0.0% |
| 2022-03-31 23:49 | 2022-03-30 | Shah Prem S | Officer - EVP and Co-President of Retail | OPT+S | $104.70 | 5,346 | $559,726 | 59,071 | 0.0% |
| 2022-03-18 23:55 | 2022-03-17 | Shah Prem S | Officer - EVP and Co-President of Retail | OPT+S | $106.65 | 4,624 | $493,150 | 59,071 | 0.0% |
| 2022-03-17 23:32 | 2022-03-15 | Moriarty Thomas M | Officer - EVP & General Counsel | OPT+S | $105.00 | 51,361 | $5,392,905 | 836,751 | 0.0% |
| 2022-02-12 00:42 | 2022-02-10 | LUDWIG EDWARD J | Director | BUY | $105.90 | 1,000 | $105,904 | 18,334 | +5.8% |
| 2022-02-05 00:46 | 2022-02-03 | Brennan Troyen A | Officer - EVP and Chief Medical Officer | OPT+S | $110.00 | 47,937 | $5,273,070 | 138,246 | 0.0% |
| 2022-02-03 00:20 | 2022-02-01 | Lotvin Alan | Officer - EVP&President-PharmacyServices | OPT+S | $106.50 | 21,386 | $2,277,566 | 61,341 | 0.0% |
| 2022-02-02 00:43 | 2022-01-28 | Clark James David | Officer - SVP, Cont & Chief Acct Officer | OPT+S | $109.00 | 6,059 | $660,431 | 17,497 | 0.0% |
| 2022-01-29 00:58 | 2022-01-27 | Roberts Jonathan C | Officer - EVP & Chief Operating Officer | OPT+S | $107.50 | 68,482 | $7,361,815 | 107,115 | 0.0% |
| 2021-11-05 23:35 | 2021-11-03 | Roberts Jonathan C | Officer - EVP & Chief Operating Officer | OPT+S | $95.00 | 108,870 | $10,342,650 | 107,115 | 0.0% |
| 2021-11-03 23:44 | 2021-11-01 | Brennan Troyen A | Officer - EVP and Chief Medical Officer | OPT+S | $90.00 | 28,159 | $2,534,310 | 138,246 | 0.0% |
| 2021-10-28 23:34 | 2021-10-26 | Brennan Troyen A | Officer - EVP and Chief Medical Officer | OPT+S | $88.00 | 82,757 | $7,282,616 | 138,246 | 0.0% |
| 2021-09-08 02:57 | 2021-09-02 | Brennan Troyen A | Officer - EVP and Chief Medical Officer | SELL | $87.00 | 2,625 | $228,375 | 140,201 | -1.8% |
| 2021-08-05 23:58 | 2021-08-05 | LUDWIG EDWARD J | Director | BUY | $79.55 | 3,000 | $238,635 | 17,334 | +20.9% |
| 2021-06-30 00:43 | 2021-06-28 | Lotvin Alan | Officer - EVP&President-PharmacyServices | SELL | $83.67 | 2,781 | $232,686 | 61,048 | -4.4% |
| 2021-06-18 00:04 | 2021-06-15 | Brennan Troyen A | Officer - EVP and Chief Medical Officer | OPT+S | $86.00 | 67,552 | $5,809,472 | 142,826 | 0.0% |
| 2021-06-08 23:48 | 2021-06-07 | Finke Daniel P | Officer - EVP/Pres, Health Care Benefits | OPT+S | $86.60 | 37,594 | $3,255,640 | 23,310 | 0.0% |
| 2021-05-13 00:30 | 2021-05-10 | Moriarty Thomas M | Officer - EVP & General Counsel | OPT+S | $86.00 | 109,469 | $9,414,334 | 0 | 0.0% |
| 2021-05-11 00:18 | 2021-05-07 | Brennan Troyen A | Officer - EVP and Chief Medical Officer | SELL | $84.00 | 9,477 | $796,068 | 144,697 | -6.1% |
| 2021-05-07 00:52 | 2021-05-04 | Boratto Eva C | Officer - EVP & CFO | SELL | $80.00 | 4,905 | $392,400 | 115,331 | -4.1% |
| 2021-04-23 23:57 | 2021-04-21 | Moriarty Thomas M | Officer - EVP & General Counsel | OPT+S | $77.00 | 103,423 | $7,963,571 | 0 | 0.0% |
| 2021-04-02 00:31 | 2021-03-31 | Clark James David | Officer - SVP, Cont & Chief Acct Officer | OPT+S | $76.00 | 5,350 | $406,600 | 7,244 | 0.0% |
| 2021-03-31 00:01 | 2021-03-29 | Moriarty Thomas M | Officer - EVP & General Counsel | OPT+S | $76.15 | 62,943 | $4,793,109 | 0 | 0.0% |
| 2021-03-30 01:55 | 2021-03-26 | Roberts Jonathan C | Officer - EVP & Chief Operating Officer | OPT+S | $74.49 | 73,433 | $5,470,024 | 664 | 0.0% |
| 2021-03-30 01:53 | 2021-03-26 | MERLO LARRY J | Director | OPT+S | $74.73 | 270,650 | $20,225,675 | 524,026 | 0.0% |
| 2021-03-24 01:15 | 2021-03-19 | Moriarty Thomas M | Officer - EVP & General Counsel | SELL | $74.15 | 49,211 | $3,648,996 | 18,226 | -73.0% |
| 2021-03-18 00:22 | 2021-03-16 | Boratto Eva C | Officer - EVP & CFO | OPT+S | $74.68 | 18,882 | $1,410,108 | 71,082 | 0.0% |
| 2021-02-18 01:04 | 2021-02-17 | LUDWIG EDWARD J | Director | BUY | $72.00 | 3,000 | $216,000 | 14,334 | +26.5% |
| 2021-01-22 01:17 | 2021-01-19 | MERLO LARRY J | Director, Officer - President and CEO | OPT+S | $77.00 | 62,893 | $4,842,761 | 523,329 | 0.0% |
| 2021-01-14 01:08 | 2021-01-12 | Bisaccia Lisa | Officer - EVP and Chief HR Officer | OPT+S | $77.00 | 25,177 | $1,938,629 | 46,588 | 0.0% |
| 2021-01-13 01:43 | 2021-01-08 | Lotvin Alan | Officer - EVP and President-CVS Caremark | OPT+S | $75.00 | 25,836 | $1,937,700 | 8,369 | 0.0% |
| 2021-01-13 01:41 | 2021-01-08 | Brennan Troyen A | Officer - EVP and Chief Medical Officer | OPT+S | $75.00 | 58,896 | $4,417,200 | 46,008 | 0.0% |
How to Interpret $CVS Trades
Not every insider transaction in CVS HEALTH Corp is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $CVS shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.
Data Source & Accuracy for CVS
Insider activity data for CVS HEALTH Corp is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $CVS, allowing you to follow the capital of those with the most intimate knowledge of the company.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.